CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA

The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic cerebral ischemia (CCI, Stage I and II) complicated by arterial hypertension. Increased contents of pro- and anti-inflammatory cytokines, IFNγ, IL- 2, G-CSF, and activation of the complement system have been revealed for these conditions, at both functional stages of the disease. The patients with stage II CCI showed elevated markers of oxygen-dependent activity in polymorphonuclear leukocytes (increased levels of spontaneous and stimulated nitroblue tetrazolium (NBT) reduction tests, phagocytic capacity and stimulation index of neutrophils). Stage I of chronic cerebral ischemia was characterized by normal values of NBT reduction tests and functional reserve of neutrophils, along with decreased stimulation index of neutrophils. Among 26 parameters of immune status, 73.1% and 80.8% of indices proved to be changed, respectively, in the patients with stage I and II CCI. 66.7% of immune indices appeared similar in magnitude and direction of changes, whereas the resting 33% are identical in orientation. Usage of Cereton and Actovegin in treatment of the stage I CCI caused normalization of 5.3% immune parameters, with partial normalization of 26.3% tests, and 68.4% of the indexes remaining unchanged or increased posttreatment. Inclusion of Glutoxim into the combined pharmacotherapy proved to be more effective since it totally normalized 52.6% of the indexes, along with partial normalization of 21.1%, while 26.3% of the indicators were not affected by the therapy. Administration of Cereton and Actovegin at the second stage of chronic brain ischemia was followed by partial normalization for 47,6% of the tests, while leaving unchanged or increased 52.4% of the indicators. Glutoxim Use fully normalize 19.0% and partially normalizes 57.1% of immune parameters.

1. Belyaeva A.S., Vanko L.V., Matveyeva N.K., Krechetova L.V. Neutrophils as regulators of immunity. Immunologiya = Immunology, 2016, Vol. 37, no. 2, pp. 129-133. (In Russ.)

2. Berezhnaya S.V., Yakupov E.Z. Neuroprotective therapy of chronic cerebral ischemia in the outpatient setting. Zhurnal nevrologii i psikhiatrii = Journal of Neurology and Psychiatry, 2015, no. 6, pp. 48-52. (In Russ.)

3. Boyajian A.S., Tsakanova G.V., Gangaram L.G., SIM R.B., Nahapetyan K.M. Involvement of the lectin of the complement cascade in the postischemic inflammatory response. Tsitokiny i vospalenie = Cytokines and Inflammation, 2010, Vol. 9, no. 3, pp. 35-39. (In Russ.)

4. Voronina E.Yu., Laskov V.B., Shulginova A.A., Konoplya A.I. Cytokine spectrum in patients with chronic ischemia of the brain (discirculatory encephalopathy) and correction of its disorders. Kurskiy nauchno-prakticheskiy vestnik “Chelovek i ego zdorovye” = Kursk Scientific Practical Bulletin “Man and his Health”, 2014, no. 1, pp. 52-58. (In Russ.)

5. Gavrilyuk E.V., Konoplya A.I., Karaulov A.V. The role of immune disorders in the pathogenesis of arterial hypertension. Immunologiya = Immunology, 2016, Vol. 37, no. 1, pp. 29-34. (In Russ.)

6. Gusev E.I., Chukanova A.S. Modern pathogenetic aspects of chronic cerebral ischemia. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry, 2015, no. 3, pp. 4-8. (In Russ.)

7. Zakharov V.V., Vakhnina N.V. Gromova D.O., Tarapovskaya A.V. Chronic cerebrovascular insufficiency: a clinical case description. Terapevticheskiy arkhiv = Therapeutic Archive, 2016, no. 4, pp. 93-99. (In Russ.)

8. Zurochka A.V., Davydova E. V., Altman D.Sh. Control of cytokine regulation of blood-brain barrier and levels of nonspecific markers of nervous tissue damage in patients with early forms of chronic ischemia of the brain. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2013, no. 7, pp. 451-455. (In Russ.)

9. Kamchatnov P.R., Salnikova S.G., Mikhailova N.A. Chronic disorders of cerebral circulation and possibility of their pharmacological correction. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry, 2012, no. 6, pp. 72-75. (In Russ.)

10. Ketlinskiy S.A., Simbirtsev A.S. Cytokines]. St. Petersburg: Foliant, 2008. 552 p.

11. Menshikov I.V., Makarova M.I., Bulatova N.I., Beduleva L.V., Abisheva N.N., Pozdeeva M.G., Sidneva N.A., Sannikova A.A., Obukhova E.V. Autoimmunity in the pathogenesis of atherosclerosis. Immunologiya = Immunology, 2010, no. 5, pp. 242-246. (In Russ.)

12. Neuroscience. National leadership / ed. by E. I. Gusev]. Moscow: GEOTAR-Media, 2009. 637 p. (In Russ.)

13. Othman I.N., Zozulya S.A., Sarmanova Z.V., Klushnik T.P. Inflammatory and autoimmune reactions in various forms of dysfunction of the nervous system. Patologicheskaya fiziologiya i eksperimentalnaya terapiya = Pathological Physiology and Experimental Therapy, 2015, Vol. 59, no. 3, pp. 81-88. (In Russ.)

14. Pekhova K.A., Mikhin V.P., Gavrilyuk E.V., Konoplya A.I. Immunometabolic disorders with hypertension of various severity level. Vestnik novykh meditsinskikh tehnologiy = Bulletin of New Medical Technologies, 2012, Vol. XIX, no. 1, pp. 172-173. (In Russ.)

15. Putilina M.V. The role of arterial hypertension in development of chronic disorders of cerebral circulation. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry, 2014, no. 9, pp. 124-128. (In Russ.)

16. Radaeva O.A., Simbirtsev A.S. Clinical and pathogenetic features of interaction of interleukin-1 and the classical vasopressor factors in patients with essential arterial hypertension. Tsitokiny i vospalenie = Cytokines and Inflammation, 2015, Vol. 14, no. 3, pp. 83-89. (In Russ.)

17. Rumyantseva S.A., Afanasiev V.V., Silina E.V. Pathophysiological basis of complex neuroprotection in cerebral ischemia. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry, 2009, no. 3, pp. 64-68. (In Russ.)

18. Svistushkin V.M., Leonov M.V., Nikiforova G.N., Pokoziy I.Yu. The application of immunomodulator Galavit in the treatment of chronic tonsillitis. Rossiyskiy meditsinskiy zhurnal = Russian Medical Journal, 2015, no. 6, p. 342. (In Russ.)

19. Serebryanaya N.B., Lobzin V.S., Kula, I.I., Ishchenko A.M. The status of the complement system at the first attack of demyelinating diseases – multiple sclerosis and clinically isolated syndrome. Tsitokiny i vospalenie = Cytokines and Inflammation, 2015, Vol. 14, no. 3, pp. 42-46. (In Russ.)

20. Симбирцев А.С. Цитокины – новая система регуляции защитных реакций организма // Цитокины и воспаление, 2002. Т. 1, № 1. С. 9-11. [Simbirtsev A.S. Cytokines – a new system of regulation of defense reactions of the organism. Tsitokiny i vospalenie = Cytokines and Inflammation, 2002, Vol. 1, no. 1, pp. 9-11. (In Russ.)]

21. 21Skvortsova V.I., Sokolov K.V., Shamalov N.A. Hypertension and cerebrovascular. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry, 2006, no. 11, pp. 57-65.

22. Solovyova E Yu., Baranova O.A., Chekanov A.V., Panasenko O.M., Chipova D.T.,Tlapshokova L.B., Myachin I.V., Karneev A.N., Fedin A.I. Study of acute and chronic inflammation in cerebral ischemia by the model of isolated neutrophils. Tsitokiny i vospalenie = Cytokines and Inflammation, 2015, Vol. 14, no. 3, pp. 60-64. (In Russ.)

23. Sologub T.V., Osinovets O.Yu. Immunomodulators in complex treatment of SARS: possible use of the drug Galavit. Russkiy meditsinskiy zhurnal = Russian Medical Journal, 2013, no. 3, pp. 144-146. (In Russ.)

24. Turova E.P., Markelova E.V., Silaev A.A., Lukyanov P.A., Chikalovets I.V. Peculiarities of cytokine status in patients with atherosclerosis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2014, Vol. 16, no. 4, pp. 323-331. (In Russ.) doi: 10.15789/1563-0625-2014-4-323-332.

25. Khaitov R.M., Ignatyeva G.A., Sidorovich I.G. Immunology. The norm and pathology]. Moscow: Medicine, 2010. 752 p. (In Russ.)

26. Shavlovskaya O.A. The use of Actovegin in neuroprotective therapy of patients with cerebrovascular disease. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry, 2013, Vol. 113, no. 6, pp. 74-76. (In Russ.)

27. Shulginova A.A. Chronic ischemia of the brain: immunometabolic violations, correction. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 4, p. 382. (In Russ.)

28. Yarilin A.A. Immunology. Moscow: GEOTAR-Media, 2010. 749 p.

29. Yarilin D.A. The role of tumor necrosis factor in the regulation of the inflammatory response of monocytes and macrophages. Immunologiya = Immunology, 2014, no. 4, pp. 195-201. (In Russ.)

30. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying ceils. Nat. Med., 2007,Vol. 13, no. 27, pp. 851-856.

31. Elmlinger M.W., Kriebel M., Ziegler D. Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro. Neuromolecular Med., 2011, Vol. 13, no. 4, pp. 266-274.

32. Khaden S.A., Gaffen S.L., Kolls J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious deseases at the mucosa. Mucossa Imunol., 2009, Vol. 2, no. 5, pp. 403-411.

33. Libby R., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, Vol. 473, pp. 317-325.

34. Lukens J.R., Gross J.M., Kanneganti T.D. IL-1 family cytokines trigger sterile inflammatory disease. Front. Immunol., 2012, no. 3, p. 315.

35. Spits H., Artis D., Colonna M., Diefenbach A., DiSanto J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., Powrie F., Vivier E. Innate lymphoid cells – aproposal for a uniform nomenclature. Nat. Rev. Immunol., 2013, Vol. 13, pp. 145-149.